TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,074 | -38.8% | 258,844 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $75,324 | -84.6% | 258,844 | 0.0% | 0.00% | -80.0% |
| Q1 2023 | $489,215 | +26.8% | 258,844 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $385,678 | -10.7% | 258,844 | 0.0% | 0.01% | -18.2% |
| Q3 2022 | $432,000 | -19.6% | 258,844 | -3.5% | 0.01% | -21.4% |
| Q2 2022 | $537,000 | -23.9% | 268,301 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $706,000 | -5.0% | 268,301 | 0.0% | 0.02% | -5.9% |
| Q4 2021 | $743,000 | -28.4% | 268,301 | 0.0% | 0.02% | -41.4% |
| Q3 2021 | $1,038,000 | -45.6% | 268,301 | -8.8% | 0.03% | -52.5% |
| Q2 2021 | $1,908,000 | -21.2% | 294,031 | 0.0% | 0.06% | -33.0% |
| Q1 2021 | $2,420,000 | -29.7% | 294,031 | 0.0% | 0.09% | -28.9% |
| Q4 2020 | $3,440,000 | +181.5% | 294,031 | +24.4% | 0.13% | +73.0% |
| Q3 2020 | $1,222,000 | – | 236,301 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |